WHO SAGE presenting its interim recommendations on the use of AstraZeneca Vaccine against COVID-19
Date:
10/02/2021
See more details
Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pneumonia, Viral/prevention & control, Viral Vaccines/immunology, Betacoronavirus/immunology, Epidemiological Monitoring, Health Communication, Viral Vaccines/supply & distribution, Vaccine Potency, Betacoronavirus/genetics, Mutation/genetics, DNA, Viral/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Risk Groups, COVID-19, AstraZeneca, Oxford
Media briefing on COVID-19 - 26/03/2021
Date:
26/03/2021
00:00:18
CL Hello. Good day to... wherever you are listening to us. Today is Friday 26th March 2021. My name is Christian Lindmeier and I'm welcoming you to today's global COVID-19 press conference. Simultaneous interpretation is provided in the six official UN languages, Arabic, Chinese, French, English, Spanish and Russian, as well as Portuguese and Hindi.
The participants today are, p...
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Health Communication, Risk Groups, Health Equity, Hospital Bed Capacity, Intensive Care Units, Americas/epidemiology, Betacoronavirus/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Viral Vaccines/immunology, Vaccine Potency, Mutation/genetics, DNA, Viral/genetics, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
COVID-19 live Q&A with Dr Mike Ryan and Dr Maria Van Kerkhove. Ask WHO of 6 January 2021
Date:
06/01/2021
#AskWHO series: This was the live discussion about the COVID-19 pandemic of 6 January 2021 with Dr Mike Ryan, Executive Director of WHO Health Emergencies Programme, and Dr Maria Van Kerkhove, WHO Technical Lead on COVID-19. Questions from the audience were taken.
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Social Isolation, Quarantine, Pandemics/prevention & control, Epidemiological Monitoring, Health Communication, Holidays, Americas/epidemiology, Risk Groups, Betacoronavirus/immunology, Viral Vaccines/immunology, Immunization Programs/organization & administration, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Masks, Betacoronavirus/genetics, Pneumonia, Viral/genetics, Coronavirus Infections/genetics, DNA, Viral/genetics, Mutation/genetics, Vaccine Potency, COVID-19